Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery

References

• Akhgari, A., Garekani, H.A., Sadeghi, F., Azimaie, M. (2005). Statistical optimization of indomethacin pellets coated with pH dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm, 305, 22–30.
   PubMed Web of Science ®Google Scholar
• Akhgari, A., Sadeghi, F., Garekani, H.A. (2006). Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm, 320, 137–42.
   PubMed Web of Science ®Google Scholar
• Alvarez-Fuentes, J., Fernández-Arévalo, M., González-Rodríguez, M.L., Cirri, M., Mura, P. (2004). Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target, 12, 607–12.
   PubMed Web of Science ®Google Scholar
• Asghar, L.F.A., Chandran, S. (2008). Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin. Pharmazie, 63, 736–42.
   PubMed Web of Science ®Google Scholar
• Ashford, M., Fell, J.T., Attwood, D., Woodhead, P.J. (1993). An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm, 91, 193–9.
   Web of Science ®Google Scholar
• Basit, A.W. (2005). Advances in colonic drug delivery. Drugs, 65, 1991–2007.
   PubMed Web of Science ®Google Scholar
• Cooper, A.M., Doshi, D.H., Patel, M.V. (1995). In vitro prolonged release of basic CNS compounds from HPMC and Carbopol 974P hydrophilic matrixes: polymer/drug ionization and counterion effects. Proc Int Symp Contr Rel Bioact Mater, 22, 288–9.
   Google Scholar
• Fernández-Hervás, M.J., Fell, J.T. (1998). Pectin/chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int J Pharm, 169, 115–9.
   Web of Science ®Google Scholar
• Follonier, N., Doelker, E. (1992). Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. STP Pharma Sci, 2, 141–55.
   Google Scholar
• Friend, D.R. (1991). Colon-specific drug delivery. Adv Drug Deliv Rev, 7, 149–99.
   Web of Science ®Google Scholar
• Fujino, H., Chen, X.B., Regan, J.W., Murayama, T. (2007). Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells. Biochem Biophys Res Commun, 359, 568–73.
   PubMed Web of Science ®Google Scholar
• Hinton, J.M., Lennard-Jonnes, J.E., Young, A.C. (1969). A new method for studying gut transit times using radioopaque markers. Gut, 10, 842.
   PubMed Web of Science ®Google Scholar
• Hosny, E.A. (1993). Polycarbophil as a controlled release matrix. Int J Pharm, 98, 235–8.
   Web of Science ®Google Scholar
• Huang, L-L., Schwartz, J.B. (1995). Studies on drug release from a carbomer tablet matrix. Drug Dev Ind Pharm, 21, 1487–501.
   Web of Science ®Google Scholar
• Hull, M.A., Gardner, S.H., Hawcroft, G. (2003). Activity of the non-steroidal anti- inflammatory drug indomethacin against colorectal cancer. Cancer Treat Rev, 29, 309–20.
   PubMed Web of Science ®Google Scholar
• Ibekwe, V.C., Liu, F., Fadda, H.M., Khela, M.K., Evans, D.F., Parsons, G.E., Basit, A.W. (2006). An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J Pharm Sci, 95, 2760–6.
   PubMed Web of Science ®Google Scholar
• Ji, C., Xu, H., Wu, W. (2007). In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS 30D-coated colon-targeted pellets of indomethacin. J Drug Target, 15, 123–31.
   PubMed Web of Science ®Google Scholar
• Kapitanović, S., čačev, T., Antica, M., Kralj, M., Cavrić, G., Krešimir, P., Spaventi, R. (2006). Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer cells. Exp Mol Path, 80, 91–6.
   PubMed Web of Science ®Google Scholar
• Khan, G.M., Meidan, V.K. (2007). Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations. Drug Dev Ind Pharm, 33, 627–39.
   PubMed Web of Science ®Google Scholar
• Kinget, R., Kalala, W., Vervoort, L., Mooter, G.U. (1998). Colonic drug targeting. J Drug Target, 6, 129–49.
   PubMed Web of Science ®Google Scholar
• Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P., Peppas, N.A. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 15, 25–35.
   Web of Science ®Google Scholar
• Krishnaiah, Y.S.R., Satyanarayana, S., Rama, Prasad YV, Narasimha, R.S. (1998). Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm, 171, 137–46.
   Web of Science ®Google Scholar
• Leong, C.W., Newton, J.M., Basit, A.W., Podczeck, F., Cummings, J.H., Ring, S.G. (2002). The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37°C. Eur J Pharm Biopharm, 54, 291–7.
   PubMed Web of Science ®Google Scholar
• Lin, S.Y., Lin, K.H., Li, M.J. (2001). Micronized ethylcellulose used for designing a directly compressed time-controlled disintegration tablet. J Contr Rel, 70, 321–8.
   PubMed Web of Science ®Google Scholar
• Lin, S.Y., Lin, K.H., Li, M.J. (2004). Formulation design of double-layer in the outershell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII). AAPS Journal, 6 (3) Article 17. Available online at: http://www.aapsj.org, Oct 31, 2008.
   Web of Science ®Google Scholar
• Luessen, H.L., Verhoef, J.C., Borchard, G., Leh, C.M., de Boer, A.G., Junginger, H.E. (1995). Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res, 12, 1293–8.
   PubMed Web of Science ®Google Scholar
• Mandayam, S., Huang, R., Tarnawski, A.S., Chiou, S.K. (2007). Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells. Apoptosis, 12, 1109–16.
   PubMed Web of Science ®Google Scholar
• Marsh, C.C., Sachuna, A.A., Sundstrom, W.R. (1986). A review of selected investigational non steroidal anti inflammatory drugs of the 1980’s. Pharmacotherapy, 6, 10–25.
   PubMed Web of Science ®Google Scholar
• Marvola, M., Nykanen, P., Rautio, S., Isonen, N., Autere, A.M. (1999). Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems. Eur J Pharm Sci, 7, 259–67.
   PubMed Web of Science ®Google Scholar
• Perez-Marcos, B., Iglesias, R., Gomez-Amoxa, J.L. (1991). Mechanical and drug release properties of atenolol-carbomer hydrophilic matrix tablets. J Contr Rel, 17, 267–76.
   Web of Science ®Google Scholar
• Ritger, P.L., Peppas, N.A. (1987). A simple equation for the description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Contr Rel, 5, 23–36.
   Google Scholar
• Rubinstein, A. (1995). Approaches and opportunities in colon- specific drug delivery. Crit Rev Ther Drug Carrier Syst, 12, 101–49.
   PubMedGoogle Scholar
• Saha, R.N., Sajeev, C., Sahoo, J. (2001). A comparative study of controlled release matrix tablets of diclofenac sodium, ciprofloxacin hydrochloride and theophylline. Drug Deliv, 8, 149–54.
   PubMed Web of Science ®Google Scholar
• Sajeev, C., Saha, R.N. (2001). Formulation and comparative evaluation of controlled release diclofenac tablets prepared by matrix- embedding technique, membrane barrier technique and combination of the two. Drug Dev Res, 53, 1–8.
   Web of Science ®Google Scholar
• Sheu, M.T., Chou, H.L., Kao, C.C., Liu, C.H., Sokoloski, T.D. (1992). Dissolution of diclofenac sodium from matrix tablets. Int J Pharm, 85, 57–63.
   Google Scholar
• Sinha, V.R., Kumria, R. (2002). Binders for colon specific drug delivery: an in vitro evaluation. Int J Pharm, 249, 23–31.
   PubMed Web of Science ®Google Scholar
• Sinha, V.R., Kumria, R. (2003). Coating polymers for colon specific drug delivery: a comparative in vitro evaluation. Acta Pharm, 53, 41–7.
   PubMedGoogle Scholar
• Taylan, B., Capan, Y., Guven, O., Kes, S., Hincall, A.A. (1996). Design and evaluation of sustained release and buccal adhesive propranolol hydrochloride tablets. J Contr Rel, 37, 11–20.
   Web of Science ®Google Scholar
• Tirosh, B.M., Baloum, T., Nassar, M., Friedman, A., Rubinstein, A. (1997). The effect of Eudragit RL-100 on the mechanical and mucoadhesion properties of polycarbophil dosage forms. J Contr Rel, 45, 57–64.
   Web of Science ®Google Scholar
• Tiwari, S.B., Krishna Murthy, T., Pai, R.M., Mehta, P.R., Chowdary, P.B. (2003). Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech, 4 (3) Article 31. Available online at: http://www.pharmscitech.org, Oct 31, 2008.
   PubMedGoogle Scholar
• Valizadeh, H., Nokhodchi, A., Qarakhani, N., Zakeri-Milani, P., Azarmi, S., Hassanzadeh, D., Löbenberg, R. (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm, 30, 303–17.
   PubMed Web of Science ®Google Scholar
• Wu, B., Deng, D., Lu, Y., Wu, W. (2007). Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs. Eur J Pharm Biopharm, 67, 707–14.
   PubMedGoogle Scholar